Ionis Pharmaceuticals, Inc. <IONS.O>: H.C. Wainwright cuts target price to $100 from $115
IONS•Related News
Nkarta to present initial Phase 1/2 autoimmune data for CAR-NK therapy NKX019 at ACR Convergence 2026
NKTX•
AppLovin Corporation <APP.O>: BTIG Cuts Target Price to $396 From $408
APP•
Herbalife launches USD 250 million share buyback program
HLF•
Best Buy Co., Inc. <BBY.N>: D. A. Davidson Cuts to Neutral From Buy
BBY•
Tonix Pharmaceuticals files Form 3 for Chief Commercial Officer Thomas Englese
TNXP•